简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

Dianthus Therapeutics推出1.5亿美元承销公开募股

2025-09-09 04:07

  • Dianthus Therapeutics (NASDAQ:DNTH) has commenced an underwritten public offering of $150M of its shares of its common stock, pre-funded warrants to purchase shares of its common stock.
  • Dianthus intends to use the net proceeds from this offering to advance the company’s preclinical and clinical development activities, as well as for working capital and general corporate purposes.
  • DNTH -7.05% after hours to $29.46.
  • Source: Press Release

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。